Diabetic amyotrophy, also known as diabetic proximal neuropathy, is a rare neuropathic complication of diabetes mellitus. It is most commonly characterized by severe pain in the hip and thigh, followed by asymmetric weakness and wasting of the proximal muscles of the lower limbs. This paper presents the case of a 68-year-old man with an 8-month history of poorly controlled Type-2 diabetes mellitus who developed progressive asymmetrical weakness and atrophy in his left thigh. After a physical examination, magnetic resonance imaging, and electrophysiological studies, diabetic amyotrophy was diagnosed. Physicians should consider the possibility of diabetic amyotrophy in patients with diabetes mellitus who exhibit primary involvement of proximal muscles of the lower limbs, marked by pain, weakness, and atrophy.
20 October 2025 in Clinical Neurology and Neurosurgery
Background: The simultaneous occurrence of Parkinson’s disease (PD)—a progressive neurodegenerative disorder marked by the loss of monoaminergic neurons in the substantia nigra—and Myasthenia gravis (MG)—a neuromuscular junction disease—is exceptionally rare. Although these conditions have different pathophysiological foundations, literature reports at least 29 cases of individuals diagnosed with both disorders. Case Report: We present the case of a 66-year-old patient treated for Parkinson’s disease for four years before being diagnosed with MG, following the onset of dysphagia and bilateral ptosis. Apomorphine infusion, an advanced treatment option, was safely initiated. Conclusion: This case highlights the coexistence of PD and MG and illustrates the potential benefits of apomorphine infusion therapy. Apomorphine was effective in reducing symptoms, improving motor function, and enhancing the patient’s quality of life.
Background: People with multiple sclerosis (MS) have a higher risk of cardiovascular disease than the general population, but the data are limited. Evaluation with strain echocardiography, a new echocardiographic method, can provide more objective data to evaluate global and segmental left ventricular systolic functions. Left ventricular Global Longitudinal Strain (GLS) may be useful in demonstrating subclinical myocardial dysfunction in MS, therefore we planned such a study. We aim to evaluate LV functions with GLS obtained with basal tissue doppler in people with MS. Material and methods: A comparison of the demographic laboratory and echocardiographic findings of the multiple sclerosis patients with strain echocardiography records registered in our hospital and the control group with similar age and gender was performed. 80 RRMS patients and 65 control group were compared. Those with another chronic disease, those who received exacerbation treatment within the last month, those outside the age range of 18–65, and other forms of progressive MS were excluded from the study. Results: GLS scores was significantly lower in the MS group(-17.05 ± 1.33 vs.18.99 ± 1.08, p < 0.001). The optimal GLS score predicted poor LV functional status in people with MS with high EDSS scores with cut-off value ≤ 17.10, sensitivity of 73%, specificity of 58% [AUC: 0.652 95% CI, (0.531–0.773), p = 0.023]. It was observed that as the EDSS score increased, that is, in the presence of worse clinical condition, the GLS score decreased (r = -0.245, p = 0.003). Conclusions: We think that strain echocardiography may be useful in demonstrating subclinical myocardial damage in people with MS. We found that as the EDSS score, that is, the severity of the disease, increases, the subclinical effect on cardiac functions increases.
Objectives: This study aimed to investigate the relationships between serum S100 calcium binding protein, neuron-specific enolase, matrix metalloproteinase-9, interleukin-6, N-terminal probrain natriuretic peptide, and N-methyl-D-aspartate receptor subunit NR2 biomarkers and futile recanalization in patients with acute ischemic stroke who were successfully recanalized with endovascular treatment. Patients and methods: In this study, 44 patients (25 males, 19 females; mean age: 62.2±14.1 years; range, 26 to 81 years) with acute ischemic stroke due to acute anterior circulation large-vessel occlusion were prospectively analyzed between May 15, 2020 and October 15, 2020. Blood samples were taken at admission, as well as 6 and 24 h after endovascular treatment. A modified Rankin Scale (mRS) was used on the 90 th day to identify futile reperfusion. Patients with mRS scores ≤2 were included in the favorable reperfusion group (n=20), while patients with mRS scores ≥3 were considered to exhibit futile reperfusion (n=24). Results: There were no significant differences between the biomarker levels of the groups (p>0.05). There was no statistically significant correlation between biomarkers and 90-day mRS scores (p>0.05). Higher National Institute of Health Stroke Scale (NIHSS) scores (p=0.004), higher number of retriever passes (p=0.032), and higher diastolic blood pressure (p=0.037) were associated with futile recanalization. Multivariate logistic regression analysis showed that a higher NIHSS score at admission was an independent predictor of futile recanalization (odds ratio=1.216, 95% confidence interval 1.01-1.46, p=0.038). Conclusion: A higher NIHSS score at admission was an independent predictor for futile recanalization. However, we concluded that biomarker levels were not associated with futile recanalization.